T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

PURPOSE: Therapies with novel mechanisms of action are needed for multiple myeloma (MM). T cells can be genetically modified to express chimeric antigen receptors (CARs), which are artificial proteins that target T cells to antigens. B-cell maturation antigen (BCMA) is expressed by normal and malign...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Brudno, Jennifer N., Maric, Irina, Hartman, Steven D., Rose, Jeremy J., Wang, Michael, Lam, Norris, Stetler-Stevenson, Maryalice, Salem, Dalia, Yuan, Constance, Pavletic, Steven, Kanakry, Jennifer A., Ali, Syed Abbas, Mikkilineni, Lekha, Feldman, Steven A., Stroncek, David F., Hansen, Brenna G., Lawrence, Judith, Patel, Rashmika, Hakim, Frances, Gress, Ronald E., Kochenderfer, James N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6067798/
https://ncbi.nlm.nih.gov/pubmed/29812997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.77.8084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados